Cardiometabolic Drugs Market Analysis

Disease Type (Congestive Heart Failure, Hypertension, Diabetes, Obesity)

The global cardiometabolic drugs market is segmented and analyzed for demand and supply by disease type into congestive heart failure, hypertension, diabetes, obesity, and others. Out of these, the diabetes segment is attributed to holding the largest share of the market during the forecast period. The major factor attributed to segment growth is the rising cases of dibetes among the people and increased diabetic inborn occurrences owing to the rising consumption of junk and adoption of an unhealthy lifestyle. Data released by International Diabetes Federation (IDF) in 2021 showed that about 537 million people aged between 20 to 79 have diabetes which is estimated to reach 783 million over the forecast period. Furthermore, instances of stress and hypertension as a result of engagement in a face-paced lifestyle are also propelling the growth of diabetes among the population which ultimately generates demand for cardiometabolic drugs for the treatment process. Also, as cardiometabolic drugs are highly effective for diabetic patients for diverse applications, such as insulin resistance, the growing diabetic population is projected to propel segment expansion and create remunerative opportunities in the global market. 

Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online)

The global cardiometabolic drugs market is also segmented and analyzed for demand and supply by distribution channel into hospitals, clinics, retail pharmacies, online, and others. Out of these five segments, the hospital segment is projected to hold the most significant share of the global market with a notable CAGR over the forecast period. Patients who are diagnosed with cardiovascular disorders and chronic diseases often visit hospitals for treatment, and it’s easier and more convenient for them to purchase the prescribed cardiometabolic drugs for treatment processes. Also, the increased inflow and outflow of patients in the hospitals is another factor for increased sales of cardiometabolic drugs through hospital settings. On the other hand, the online segment is also estimated to garner a noteworthy segment share by the end of the assessment period owing to the escalation of the number of online pharmacies selling cardiometabolic drugs amongst the population worldwide. Furthermore, the purchase of cardiometabolic drugs is very much convenient as one doesn’t have to physically visit a hospital, clinic, or pharmacy for the purchase. In addition to that, another growth factor for the expansion of segment size is the huge offers and rewards offered by various online pharmaceutical businesses to lure customers.

Our in-depth analysis of the global market includes the following segments: